Basic fibroblast growth factor-induced activation of novel CREB kinase during the differentiation of immortalized

J Y Sung1, S W Shin, Y S Ahn

  • 1Department of Pharmacology, Brain Research Institute, and Brain Korea 21 Projects for Medical Science, Yonsei University College of Medicine, Seoul 120-752, Korea.

Insights

Basic fibroblast growth factor (bFGF) triggers a novel signaling pathway to activate CREB (cAMP response element-binding protein) in hippocampal cells. This pathway is crucial for cell differentiation and gene transcription.

Area of Science:

  • Cell biology
  • Molecular signaling
  • Neuroscience

Background:

  • Growth factors regulate cell proliferation, differentiation, and survival by binding to cell surface receptors.
  • Signal transduction pathways relay extracellular signals to the nucleus, influencing gene expression.
  • The transcription factor CREB (cAMP response element-binding protein) plays a key role in these cellular processes.

Purpose of the Study:

  • To investigate the signaling mechanism by which basic fibroblast growth factor (bFGF) activates CREB in immortalized hippocampal progenitor cells (H19-7).
  • To identify the specific pathways involved in bFGF-induced CREB phosphorylation and subsequent gene transcription.

Main Methods:

  • Utilized immortalized hippocampal progenitor cells (H19-7).
  • Examined CREB phosphorylation at Ser(133) residue using bFGF and epidermal growth factor (EGF).
  • Assessed CRE-mediated gene transcription and cell differentiation.
  • Employed in vitro in-gel kinase assays to identify novel kinases.

Main Results:

  • bFGF induced prolonged phosphorylation of CREB at Ser(133), leading to increased CRE-mediated gene transcription and H19-7 cell differentiation.
  • Expression of a non-phosphorylatable CREB mutant (S133A) blocked bFGF-induced differentiation.
  • bFGF-induced CREB phosphorylation kinetics differed from EGF, suggesting a distinct pathway.
  • Known signaling pathways (MAPK, PKA, PKC, PI3K-p70S6K, CaMK, CK2) did not mediate bFGF-induced CREB phosphorylation.
  • A novel 120-kDa bFGF-inducible CREB kinase was identified.

Conclusions:

  • bFGF activates a novel signaling pathway in hippocampal progenitor cells that leads to CREB phosphorylation and activation.
  • This pathway is distinct from previously known signaling cascades.
  • The identified bFGF-inducible CREB kinase is a key component of this new signaling mechanism.
  • This discovery provides new insights into growth factor-mediated regulation of gene expression and cell differentiation.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Forced Transdifferentiation01:28

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...